Neuronal intranuclear inclusion disease with subclinical peripheral neuropathy: A case report

Lu Sun,Lihua Zhou,Liyan Ren,Chunru Han,Qun Xue,Linqing Ma
DOI: https://doi.org/10.1097/md.0000000000040636
IF: 1.6
2024-11-28
Medicine
Abstract:Neuronal intranuclear inclusion disease (NIID) is a slowly progressive neurodegenerative disease characterized by eosinophilic intranuclear inclusions in various tissue cells. [ 1 ] NIID was first reported by Lindenberg et al in 1968. [ 2 ] In 2011, Sone et al discovered eosinophilic intranuclear inclusions in the skin tissue of patients with NIID. [ 3 ] Since then, the rates of diagnosis of patients with NIID have increased significantly. Initially, the primary methods for diagnosing this disease were abnormally high signal intensity in the corticomedullary junction on diffusion-weighted magnetic resonance imaging (MRI) and characteristic findings on skin biopsy. [ 4 , 5 ] In 2019, a GGC repeat expansion mutation in the untranslated region of the notch 2 N-terminal like C ( NOTCH2NLC ) gene was identified as the causative agent of NIID, [ 6–9 ] providing crucial evidence for the diagnosis of the disease.
medicine, general & internal
What problem does this paper attempt to address?